Zobrazeno 1 - 10 of 56 pro vyhledávání: '"Matthew R Wilson"'
1
Akademický článek
Brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma in the United Kingdom: A real‐world intention‐to‐treat analysis
Autor: Maeve A. O'Reilly, William Wilson, David Burns, Andrea Kuhnl, Frances Seymour, Ben Uttenthal, Caroline Besley, Rajesh Alajangi, Thomas Creasey, Shankara Paneesha, Johnathon Elliot, Carlos Gonzalez Arias, Sunil Iyengar, Matthew R. Wilson, Alison Delaney, Lourdes Rubio, Jonathan Lambert, Khalil Begg, Stephen Boyle, Kathleen P. L. Cheok, Graham P. Collins, Claire Roddie, Rod Johnson, Robin Sanderson
Publikováno v: HemaSphere, Vol 8, Iss 6, Pp n/a-n/a (2024)
Abstract Brexucabtagene autoleucel (brexu‐cel) is an autologous CD19 CAR T‐cell product, approved for relapsed/refractory (r/r) mantle cell lymphoma (MCL). In ZUMA‐2, brexu‐cel demonstrated impressive responses in patients failing ≥2 lines,
Externí odkaz: https://doaj.org/article/2580c990e3d748ad908ab8da5f93b054
Zobrazit plný text záznamu
5
CNS prophylaxis in aggressive B-cell lymphoma
Autor: Matthew R. Wilson, Sabela Bobillo, Kate Cwynarski
Publikováno v: Hematology Am Soc Hematol Educ Program
The prevention of central nervous system (CNS) relapse in diffuse large B-cell lymphoma (DLBCL) continues to be one of the most contentious areas of lymphoma management. Outcomes for patients with secondary CNS lymphoma (SCNSL) have historically been
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::076234492d5bd0cd785a55def3f0312f
https://pubmed.ncbi.nlm.nih.gov/36485105
Zobrazit plný text záznamu
6
CNS prophylaxis for diffuse large B-cell lymphoma
Autor: Toby A Eyre, Kerry J Savage, Chan Y Cheah, Tarec C El-Galaly, Katharine L Lewis, Pamela McKay, Matthew R Wilson, Andrew M Evens, Sabela Bobillo, Diego Villa, Matthew J Maurer, Kate Cwynarski, Andrés J M Ferreri
Publikováno v: Eyre, T A, Savage, K J, Cheah, C Y, El-Galaly, T C, Lewis, K L, McKay, P, Wilson, M R, Evens, A M, Bobillo, S, Villa, D, Maurer, M J, Cwynarski, K & Ferreri, A J M 2022, ' CNS prophylaxis for diffuse large B-cell lymphoma ', The Lancet Oncology, vol. 23, no. 9, pp. e416-e426 . https://doi.org/10.1016/S1470-2045(22)00371-0
CNS relapse in the brain parenchyma, eyes, or leptomeninges is an uncommon but devastating complication of diffuse large B-cell lymphoma. CNS prophylaxis strategies, typically involving intrathecal or high-dose antimetabolites, have been developed in
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9aa3c1e3efbbf620a467525e4e71a0a3
https://pubmed.ncbi.nlm.nih.gov/36055310
Zobrazit plný text záznamu
8
Timing of high dose methotrexate CNS prophylaxis in DLBCL:a multicenter international analysis of 1,384 patients
Autor: Matthew R. Wilson, Toby A. Eyre, Amy A. Kirkwood, Nicole Wong Doo, Carole Soussain, Sylvain Choquet, Nicolás Martinez-Calle, Gavin Preston, Matthew Ahearne, Elisabeth Schorb, Marie-Pierre Moles-Moreau, Matthew Ku, Chiara Rusconi, Jahanzaib Khwaja, Mayur Narkhede, Katharine L. Lewis, Teresa Calimeri, Eric Durot, Loïc Renaud, Andreas Kiesbye Øvlisen, Graham McIlroy, Timothy J. Ebsworth, Johnathan Elliot, Anna Santarsieri, Laure Ricard, Nimish Shah, Qin Liu, Adam S. Zayac, Francesco Vassallo, Laure Lebras, Louise Roulin, Naelle Lombion, Kate Manos, Ruben Fernandez, Nada Hamad, Alberto Lopez-Garcia, Deirdre O'Mahony, Praveen Gounder, Nathalie Forgeard, Charlotte Lees, Kossi Agbetiafa, Tim Strüßmann, Thura Win Htut, Aline Clavert, Hamish Scott, Anna Guidetti, Brett R. Barlow, Emmanuelle Tchernonog, Jeffery Smith, Fiona Miall, Christopher P. Fox, Chan Y. Cheah, Tarec Christoffer El Galaly, Andrés J. M. Ferreri, Kate Cwynarski, Pamela McKay
Publikováno v: Wilson, M R, Eyre, T A, Kirkwood, A A, Wong Doo, N, Soussain, C, Choquet, S, Martinez-Calle, N, Preston, G, Ahearne, M J, Schorb, E, Moles-Moreau, M-P, Ku, M, Rusconi, C, Khwaja, J, Narkhede, M, Lewis, K L, Calimeri, T, Durot, E, Renaud, L, Øvlisen, A K, Mcilroy, G, Ebsworth, T J, Elliot, J, Santarsieri, A, Ricard, L, Shah, N, Liu, Q, Zayac, A S, Vassallo, F, Lebras, L, Roulin, L, Lombion, N, Manos, K, Fernandez, R, Hamad, N, Lopez-Garcia, A, O'Mahony, D, Gounder, P, Forgeard, N, Lees, C, Agbetiafa, K, Strüessmann, T, Htut, T W, Clavert, A, Scott, H, Guidetti, A, Barlow, B R, Tchernonog, E, Smith, J, Miall, F, Fox, C P, Cheah, C Y, El Galaly, T C, Ferreri, A J M, Cwynarski, K & McKay, P 2022, ' Timing of high dose methotrexate CNS prophylaxis in DLBCL : a multicenter international analysis of 1,384 patients ', Blood, vol. 139, no. 16, pp. 2499-2511 . https://doi.org/10.1182/blood.2021014506
Prophylactic high-dose methotrexate (HD-MTX) is often used for diffuse large B-cell lymphoma (DLBCL) patients at high risk of central nervous system (CNS) relapse, despite limited evidence demonstrating efficacy or the optimal delivery method. We con
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::906a66418f9b1bfafd3fd14b33943dce
https://vbn.aau.dk/da/publications/4c8d4993-b73b-4f50-a5d0-8e283e951137
Zobrazit plný text záznamu
9
In Vitro Characterization of the Colibactin-Activating Peptidase ClbP Enables Development of a Fluorogenic Activity Probe
Autor: Ethan S. Winter, Emily P. Balskus, Matthew R. Volpe, Matthew R. Wilson, Carolyn A. Brotherton, Sheila E. Johnson
Publikováno v: ACS Chem Biol
The gut bacterial genotoxin colibactin has been linked to the development of colorectal cancer. In the final stages of colibactin’s biosynthesis, an inactive precursor (pre-colibactin) undergoes proteolytic cleavage by ClbP, an unusual inner-membra
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23494fe88700cbefc5cd14bee65d4548
https://doi.org/10.1021/acschembio.9b00069
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje